Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 13, 2022
Patent Application Number
17004109
Date Filed
August 27, 2020
Patent Citations Received
Patent Primary Examiner
The present invention provides compounds of Formula I′, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
